1. Home
  2. GGB vs ABVX Comparison

GGB vs ABVX Comparison

Compare GGB & ABVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gerdau S.A.

GGB

Gerdau S.A.

SELL

Current Price

$5.02

Market Cap

8.8B

Sector

Industrials

ML Signal

SELL

Logo Abivax SA American

ABVX

Abivax SA American

SELL

Current Price

$87.62

Market Cap

7.6B

Sector

N/A

ML Signal

SELL

Company Overview

Basic Information
Metric
GGB
ABVX
Founded
1901
2013
Country
Brazil
France
Employees
N/A
N/A
Industry
Steel/Iron Ore
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
8.8B
7.6B
IPO Year
2000
2022

Fundamental Metrics

Financial Performance
Metric
GGB
ABVX
Price
$5.02
$87.62
Analyst Decision
Buy
Strong Buy
Analyst Count
5
12
Target Price
$5.76
★ $163.58
AVG Volume (30 Days)
★ 11.9M
1.3M
Earning Date
10-26-2026
09-21-2026
Dividend Yield
★ 2.59%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$1.24
N/A
Revenue Next Year
$3.35
$1,695.54
P/E Ratio
$13.89
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.14
$69.81
52 Week High
$5.48
$148.83

Technical Indicators

Market Signals
Indicator
GGB
ABVX
Relative Strength Index (RSI) 51.28 37.71
Support Level $4.86 $84.11
Resistance Level $5.18 $128.68
Average True Range (ATR) 0.15 3.45
MACD 0.00 0.56
Stochastic Oscillator 44.71 26.16

Price Performance

Historical Comparison
GGB
ABVX

About GGB Gerdau S.A.

Gerdau SA produces steel and steel products. The company operates in civil construction, agriculture, automotive, iron ore, exports, research and development, and home steel products sectors. It offers products such as Semi-finished products (Billets, Blooms and Slabs), Special bar quality, Common Long Rolled Products, Dawn products, Merchant bar, Beams, Rebar, Piling, Iron Ore and Others. The company's geographical segment includes Brazil Segment; North America Segment; and South America Segment. It derives the majority of its revenue from the Brazil Operations segment, which includes the long, flat and special steel operations and the iron ore operation located in Brazil and joint ventures and associated companies located in Brazil.

About ABVX Abivax SA American

Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. The company is evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two common forms are UC and CD. The Group operates in a single operating segment: R&D of pharmaceutical products in order to market them in the future.

Share on Social Networks: